Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 4
1983 1
1984 1
1985 2
1986 4
1987 5
1988 3
1989 7
1990 6
1991 16
1992 12
1993 11
1994 9
1995 13
1996 25
1997 22
1998 34
1999 44
2000 44
2001 53
2002 69
2003 79
2004 98
2005 119
2006 140
2007 176
2008 182
2009 229
2010 300
2011 315
2012 340
2013 355
2014 482
2015 569
2016 507
2017 629
2018 720
2019 749
2020 828
2021 871
2022 1070
2023 1055
2024 1277
2025 530

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,666 results

Results by year

Filters applied: . Clear all
Page 1
G3BP1 promotes DNA binding and activation of cGAS.
Liu ZS, Cai H, Xue W, Wang M, Xia T, Li WJ, Xing JQ, Zhao M, Huang YJ, Chen S, Wu SM, Wang X, Liu X, Pang X, Zhang ZY, Li T, Dai J, Dong F, Xia Q, Li AL, Zhou T, Liu ZG, Zhang XM, Li T. Liu ZS, et al. Among authors: dai j. Nat Immunol. 2019 Jan;20(1):18-28. doi: 10.1038/s41590-018-0262-4. Epub 2018 Dec 3. Nat Immunol. 2019. PMID: 30510222 Free PMC article.
CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.
Tang Z, Xu Y, Tan Y, Shi H, Jin P, Li Y, Teng J, Liu H, Pan H, Hu Q, Cheng X, Ye J, Su Y, Sun Y, Meng J, Zhou Z, Chi H, Wang X, Liu J, Lu Y, Liu F, Dai J, Yang C, Chen S, Liu T. Tang Z, et al. Among authors: dai j. Nat Commun. 2023 Aug 21;14(1):5077. doi: 10.1038/s41467-023-40824-7. Nat Commun. 2023. PMID: 37604832 Free PMC article.
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.
Mao L, Lian B, Li C, Bai X, Zhou L, Cui C, Chi Z, Sheng X, Wang X, Tang B, Yan X, Li S, Kong Y, Dai J, Wei X, Li J, Duan R, Xu H, Wu X, Yang Y, Cheng F, Zhang C, Xia F, Pang Z, Guo J, Si L. Mao L, et al. Among authors: dai j. JAMA Oncol. 2023 Aug 1;9(8):1099-1107. doi: 10.1001/jamaoncol.2023.1363. JAMA Oncol. 2023. PMID: 37261804 Free PMC article. Clinical Trial.
10,666 results
You have reached the last available page of results. Please see the User Guide for more information.